Corporate Giving and Grants

Home > About Us > Corporate Responsibility > Corporate Giving and Grants

Submit a Grant Request

  • Overview
  • Historical Timeline
  • Executive Team
  • Board of Directors
  • Corporate Responsibility
    • Corporate Giving and Grants
    • Prescriber Data Privacy
    • Code of Conduct
    • Compliance Reporting
    • Corporate Compliance
  • Corporate Values
  • Partnering with Onyx
    • Partnerships
  • Awards and Recognitions
  • Contact Us
  • Home
  • About Us
    • Overview
    • Historical Timeline
    • Executive Team
    • Board of Directors
    • Corporate Responsibility
    • Corporate Values
    • Partnering with Onyx
    • Awards and Recognitions
    • Contact Us
  • Therapies
    • Overview
    • Nexavar ® for Advanced Kidney Cancer
    • Nexavar ® for Unresectable Liver Cancer
    • Patient Access
  • Clinical Development
    • Overview
    • Clinical Pipeline
    • Sorafenib
    • Carfilzomib
    • Oprozomib (formerly ONX 0912)
    • ONX 0914
    • Cell Cycle Kinase Inhibitor
  • Investors
    • Overview
    • Event Calendar
    • Analyst Coverage
    • SEC Filings
    • Financial Information
    • Stock Information
    • Annual Report
    • Proxy Materials
    • Corporate Governance
    • Litigation Update
    • Information Request
  • News & Media
    • Overview
    • Press Releases
    • Online Media Kit
  • Careers
    • Overview
    • Job Openings
    • Benefits
    • How to Apply
  • Contact Us
  • Site Map
© Onyx 2012    
  • Terms of Use
  • Home
  • About Us
    • Overview
    • Historical Timeline
    • Executive Team
    • Board of Directors
    • Corporate Responsibility
    • Corporate Values
    • Partnering with Onyx
    • Awards and Recognitions
    • Contact Us
  • Therapies
    • Overview
    • Nexavar ® for Advanced Kidney Cancer
    • Nexavar ® for Unresectable Liver Cancer
    • Patient Access
  • Clinical Development
    • Overview
    • Clinical Pipeline
    • Sorafenib
    • Carfilzomib
    • Oprozomib (formerly ONX 0912)
    • ONX 0914
    • Cell Cycle Kinase Inhibitor
  • Investors
    • Overview
    • Event Calendar
    • Analyst Coverage
    • SEC Filings
    • Financial Information
    • Stock Information
    • Annual Report
    • Proxy Materials
    • Corporate Governance
    • Litigation Update
    • Information Request
  • News & Media
    • Overview
    • Press Releases
    • Online Media Kit
  • Careers
    • Overview
    • Job Openings
    • Benefits
    • How to Apply
  • Glossary